Adimmune Corporation

TWSE:4142.TW

22 (TWD) • At close November 14, 2024
Bedrijfsnaam Adimmune Corporation
Symbool 4142.TW
Munteenheid TWD
Prijs 22
Beurswaarde 9,273,176,000
Dividendpercentage 0%
52-weken bereik 22 - 36.6
Industrie Biotechnology
Sector Healthcare
CEO Mr. Chi-Hsien Chan
Website https://www.adimmune.com.tw

An error occurred while fetching data.

Over Adimmune Corporation

Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified

Vergelijkbare Aandelen

ScinoPharm Taiwan, Ltd. logo

ScinoPharm Taiwan, Ltd.

1789.TW

23 TWD

Tanvex BioPharma, Inc. logo

Tanvex BioPharma, Inc.

6541.TW

63.3 TWD

YungShin Global Holding Corporation logo

YungShin Global Holding Corporation

3705.TW

53.5 TWD

Excelsior Medical Co., Ltd. logo

Excelsior Medical Co., Ltd.

4104.TW

86.3 TWD

Grape King Bio Ltd logo

Grape King Bio Ltd

1707.TW

151 TWD

Panion & Bf Biotech Inc. logo

Panion & Bf Biotech Inc.

1760.TW

90.6 TWD

SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc.

4119.TW

94.9 TWD

Standard Chem & Pharm CO., LTD. logo

Standard Chem & Pharm CO., LTD.

1720.TW

63.3 TWD

China Chemical & Pharmaceutical Co., Ltd. logo

China Chemical & Pharmaceutical Co., Ltd.

1701.TW

21.15 TWD

CHC Healthcare Group logo

CHC Healthcare Group

4164.TW

39.75 TWD

Financiële Gegevens

Cijfers zijn in miljoenen (TWD)

Cijfers zijn in miljoenen (TWD)